Page last updated: 2024-11-05

tranexamic acid and Hyaline Membrane Disease

tranexamic acid has been researched along with Hyaline Membrane Disease in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).

Research Excerpts

ExcerptRelevanceReference
"The role of fibrinolysis in the pathogenesis of hyaline membrane disease was studied in newborn rabbits at 28- or 29-day gestation."7.66Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits. ( Oda, T; Sueishi, K; Tanaka, K, 1978)
"The role of fibrinolysis in the pathogenesis of hyaline membrane disease was studied in newborn rabbits at 28- or 29-day gestation."3.66Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits. ( Oda, T; Sueishi, K; Tanaka, K, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sueishi, K1
Tanaka, K1
Oda, T1

Other Studies

1 other study available for tranexamic acid and Hyaline Membrane Disease

ArticleYear
Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits.
    Virchows Archiv. A, Pathological anatomy and histology, 1978, Jun-15, Volume: 378, Issue:3

    Topics: Animals; Fibrin; Fibrinogen; Fibrinolysis; Humans; Hyaline Membrane Disease; Hypoxia; Infant, Newbor

1978